Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01813110 · ClinicalTrials.gov registry record · NA
Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01813110 is a NA study that has completed, run by Penn State University. The registered enrollment target is 21 participants.
The verdict
NCT01813110, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the marine omega-3 fatty acids can attenuate inflammatory responses to endotoxin challenge.
Interventions
- DRUG Placebo
- DRUG 4 g prescription omega-3 concentrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01813110
The ClinicalTrials.gov registry entry for NCT01813110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01813110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01813110 about?
NCT01813110 is a clinical study titled "Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation". The purpose of this study is to assess whether the marine omega-3 fatty acids can attenuate inflammatory responses to endotoxin challenge.
What is the current status of trial NCT01813110?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-05. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01813110?
The interventions under investigation include: Placebo (DRUG), 4 g prescription omega-3 concentrate (DRUG).
Who is sponsoring clinical trial NCT01813110?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.